跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 86 条关于
“CergenX”
全部
86
临床试验
17
药物
22
机构
22
资讯
25
去年
CergenX's AI-Powered Wave Device Receives FDA Breakthrough Designation for Neonatal Brain Monitoring
3年前
Vergent Bioscience Completes Enrollment in Phase 2 Trial of Abenacianine for Enhanced Tumor Visualization During Lung Cancer Surgery
去年
Vergent Bioscience Completes Phase 2 Trial Enrollment of Abenacianine for Enhanced Lung Tumor Visualization
去年
Cereno Scientific Secures SEK 250 Million in Debt Financing to Advance Clinical Programs
去年
Cereno Scientific Expands Access to CS1 for Pulmonary Arterial Hypertension
2年前
argenx Outlines 'Vision 2030' with Focus on Autoimmune Disease Therapies
去年
Cereno Scientific Secures Funding to Advance Pulmonary Hypertension and Fibrosis Programs
去年
Argenx Partners with Unnatural Products in $1.5 Billion Macrocyclic Peptide Deal
去年
VYVDURA Approved in Japan for Chronic Inflammatory Demyelinating Polyneuropathy
去年
Argenx Expands Partnership with Fujifilm Biotechnologies to Manufacture Efgartigimod in the U.S.
第 1 页,共 3 页
上一页
下一页